Medicament "Cinnarizine" presented biconvex round tablets containing 25 mg of active substance - cinnarizine.In addition, the product contains wheat starch, lactose, colloidal silicon dioxide, povidone K25 and magnesium stearate.The drug is designed to block calcium channels and affect the vessels of the brain.
As a result of "Cinnarizinum" cells lack of calcium ions, which leads to a decrease in the tone of smooth muscles of arterioles and increased vasodilating action of carbon dioxide.The vessels of the brain begin to slightly react to nutrients - norepinephrine, epinephrine, angiotensin, dopamine, and others. The drug reduces allergic reactions and the excitability of the vestibular apparatus, as well as removes the tone of the nervous system.It is indicated for cerebrovasc
ular insufficiency and hypoxia.
drug is absorbed into the digestive tract, it is metabolized in the liver and excreted in the urine and feces.Patients with blood circulation of the brain to take 1-2 tablets 3 times a day.Suffering from disorders of peripheral blood circulation increases the dose of 2-3 tablets per day.Patients with vestibular disorders take 1 tablet three times a day.And those who are swayed on the road, you can drink 1 tablet half an hour before the trip, and if necessary, to drink another 6 hours.The drug is taken after meals.The course of treatment may last several months.
drug indicated for ischemic stroke, post-stroke conditions, dyscirculatory entsefalopotii, head trauma, vestibular disorders, senile dementia, migraine, disorders of peripheral blood circulation.Is contraindicated in persons with hypersensitivity, as well as pregnant and lactating women.The day may be taken no more than 9 tablets.In case of overdose gastric lavage and make charcoal.The drug can increase the effects of alcohol and sedatives.
Side effects can be distinguished headache, drowsiness, fatigue, pain in the epigastric pain, dry mouth, dyspepsia, allergic reactions, decreased blood pressure, skin rash and sweating.Please note that during the treatment "Cinnarizinum" should refrain from activities that require high concentration and psychomotor reactions.The drug can give a false positive result in doping control athletes and conduct of diagnostic skin tests.
Patients receiving long-term "Cinnarizine", should be examined the liver, kidneys and regularly donate blood for analysis.Individuals with Parkinson's disease drug therapy is indicated only in cases where the benefits of its use far exceeds the risk of possible degradation.The preparation is available on medical prescription.